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Abstract 
 
Objectives: We aimed to determine an optimal cut-off score for the Clock Drawing Test 
(CDT), scored by the scale of Freund, for efficient screening for cognitive impairment in elderly 
(cancer) patients within a Comprehensive Geriatric Assessment (CGA) and to compare the 
Freund CDT to the Mini-Cog. 
Materials and Methods: Data of 221 elderly (≥ 70 y) patients, comprising of an OncoGeriatric 
(OG) and General Geriatric (GG) group, were retrospectively reviewed. All patients were 
evaluated with both the CDT and Mini Mental State Examination (MMSE) as the gold standard. 
Receiver Operating Characteristics (ROC) analysis was used to determine diagnostic 
performance. A pre-established algorithm was applied to retrieve Mini-Cog results through a 
combination of the CDT and the 3-word delayed recall (3-WDR) test (included within MMSE).  
Results: Data of 105 OG and 116 GG patients were evaluated. Potential cognitive impairment 
(MMSE ≤ 23) was detected in 29.5% and 65.8% of patients, respectively. The CDT showed 
good diagnostic accuracy in the OG (0.88±0.03) and GG (0.85±0.03) group, based on the Area 
Under the ROC Curve (AUC ± SE). CDT (cut-off ≤ 4) provided good sensitivity (80.7%) and 
specificity (81.1%) in the OG group and excellent sensitivity (89.6%) and moderate specificity 
(51.3%) in the GG group. Addition of the 3-WDR test, to form the Mini-Cog, resulted in similar 
positive and negative predictive values for the OG group and higher negative predictive value 
for the GG group. 
Conclusion: These data suggest that the Freund CDT, at the cut-off score of ≤ 4, is promising 
for use within a CGA. The Mini-Cog might be preferable in the GG population. 
 
